Published by Josh White on 26th August 2021
(Sharecast News) - Immunotherapy developer Scancell announced on Thursday that the UK Medicines and Healthcare products Regulatory Authority (MHRA) has approved the clinical trial application to initiate the first-in-human phase 1 and 2 clinical study of 'Modi-1'.
URL: http://www.digitallook.com/dl/news/story/32082934/...